| Date |
Title |
Topic |
| 5/3/12 |
It’s NIGH Time |
GHTC report on prod dev |
| 4/26/12 |
Climatic Change-Up |
Dengue vaccine |
| 4/19/12 |
Boot Straps |
Essential health plans |
| 4/12/12 |
MONGO Bingo |
GH startups |
| 4/5/12 |
BD Needy |
BVGH report |
| 3/29/12 |
Virtual Reality Biotech |
Dual market startups |
| 3/22/12 |
Crossing My Desk |
Newsy items |
| 3/15/12 |
A Tale of Two Companies |
MEND and Breathable Foods |
| 3/8/12 |
On the Drawing Board |
TB Dx |
| 3/1/12 |
TB Dx: Getting There |
TB Dx |
| 2/23/12 |
Hunting the Elusive Snark |
BIO panel, public sector |
| 2/16/12 |
Orphaned and Neglected |
Orphan Drug Act |
| 2/9/12 |
Putting the Biz into BoP |
BoP pharma report |
| 2/2/12 |
NTD TD |
NTD effort |
| 1/26/12 |
The Three-Point Shot |
Vaccine deals |
| 1/19/12 |
A Better World? |
AUTM report |
| 1/12/12 |
PATH Finding |
PATH, impact measurement |
| 1/5/12 |
Too Big to Flail |
OWH takeover |
| 12/29/11 |
More Grease for the COGs |
Biomanufacturing |
| 12/22/11 |
Ringing in the New Year (and in My Head) |
Vaccines |
| 12/15/11 |
Innovate or Die |
ROW healthcare |
| 12/8/11 |
No Kiddin’ |
Pediatric GH |
| 12/1/11 |
PET Friendly |
Rabies vaccine franchise |
| 11/25/11 |
Revenge of the Microbes II |
EU AMR program |
| 11/18/11 |
A Long Strange Trip |
Malaria drug development |
| 11/10/11 |
Verify Then Trust |
Data, PDPs |
| 11/3/11 |
Window Dressing |
WIPO ReSearch, BVGH |
| 10/27/11 |
Made in China |
China, ROW markets |
| 10/20/11 |
Not So NICE |
Pharma model |
| 10/13/11 |
Beyond the Band-Aid |
SMEs, new GH group |
| 10/6/11 |
Free Advice, Trevor |
New Gates guy |
| 9/29/11 |
Drug Bust |
US market |
| 9/22/11 |
Biosimilar Fever |
Biosimilar market |
| 9/15/11 |
Generics Play |
Generics and Cipla |
| 9/8/11 |
Market Failure |
Cancer drug shortage |
| 9/1/11 |
Gone Fishin’ |
Cheaper DD/NuMedii |
| 8/25/11 |
A Better Type of Prize |
Lem-MIT prize |
| 8/18/11 |
Missing the Boat |
ROW markets |
| 8/11/11 |
mmmmHeatlh |
Health hotlines |
| 8/4/11 |
S and M |
Sales intermediates |
| 7/28/11 |
A Quiet Week at Lake Woebegone |
DAT, UNITAID, MenAfriVac |
| 7/21/11 |
Eyes on the Prize |
Epistem TB Dx |
| 7/14/11 |
USAID: Rhetoric or Reality? |
Tech devel support |
| 7/7/11 |
Backyard Biotech |
Virtual biotech model |
| 6/30/11 |
Over to the Dark Side |
Yamada’s new job |
| 6/23/11 |
Thinking Out of the Box Reprise |
SE |
| 6/16/11 |
Healthy, Wealthy, and Wise Reprise |
SE |
| 6/9/11 |
A Pleasant Surprise Reprise |
SE |
| 6/2/11 |
USAID and Innovation Reprise |
SE |
| 5/26/11 |
Checking the Pool’s Temperature |
BVGH IP pool |
| 5/19/11 |
Micro Need Macro Problem |
IDD and IBET |
| 5/12/11 |
This Little Piggy |
ROW healthcare |
| 5/5/11 |
Nuts and Bolts |
BVGH Forum |
| 4/28/11 |
Skin in the Game |
CFFT, PDP BD |
| 4/21/11 |
Revenge of the Microbes |
Drug-resistance |
| 4/14/11 |
BMGF Ventures LLP |
BMGF Liquidia PRI |
| 4/7/11 |
B2B2B2B |
HIGH Dx mtg |
| 3/31/11 |
TB DD Needy |
TB pipeline |
| 3/24/11 |
Deal of the Year 2011 |
Biocon/Pfizer deal |
| 3/17/11 |
Bits and Byes from the Info-stream |
DD cost, euSEND, BVGH |
| 3/10/11 |
Creditworthy |
Tax credits |
| 3/3/11 |
Open Source Sesame |
OS for NG DD |
| 2/24/11 |
Brother, Can You Spare a Dime (or Five)? |
NTD treatment |
| 2/17/11 |
Slicing the Baloney |
DD by academia |
| 2/10/11 |
Greasing the COGs |
Vax manu |
| 2/3/11 |
Bugs in the Ointment |
Malaria vax |
| 1/27/11 |
Starting Uphill |
Nonex licensing |
| 1/20/11 |
A Plan for Essential Care |
SWAps and EHPs |
| 1/13/11 |
ReDuX Part II |
Diagnostics |
| 1/6/11 |
ReDuX |
Diagnostics |
| 12/29/10 |
A Shot in the Arm |
Vaccines in 2011 |
| 12/23/10 |
Kvetching |
Review of posts |
| 12/16/10 |
Watch Out Big Pharma? |
Meng Vac Progm |
| 12/9/10 |
Yet Another |
R4D Institute |
| 12/2/10 |
AIDS Aid (Maybe) |
Ditto |
| 11/28/10 |
Thanksgiving |
HIV thera vaccine |
| 11/18/10 |
Thanks but No Thanks |
MGH GH Ctr Symp |
| 11/11/10 |
Pharma, Reinvent Thyself |
SE |
| 11/4/10 |
Drug Development on the Cheap |
SE |
| 10/28/10 |
Affordability Revisited |
Health care delivery |
| 10/21/10 |
Start Up Mode |
Networking, GATE |
| 10/14/10 |
Affordability |
Health insurance |
| 10/7/10 |
Holy Grail Horse Race |
Dry powder vaccines |
| 9/30/10 |
Smart Money |
Industry drug devel |
| 9/23/10 |
Healthy, Wealthy, and Wise |
ROW companies |
| 9/16/10 |
Mending the Gap |
MTHG meeting |
| 9/7/10 |
Market Tested and Not-yet Approved |
Hlth Mrkt Innovs |
| 9/2/10 |
Singin’ Be-BOP |
App technology |
| 8/26/10 |
Beached |
Update on posts |
| 8/19/10 |
Mid-August Meander |
More reflection |
| 8/12/10 |
Patents Persona Non Grata |
Big pharma patents |
| 8/5/10 |
Knickers in a Twist |
Unitaid patent pool |
| 7/29/10 |
A Really Neglected Disease |
Sickle cell disease |
| 7/22/10 |
I’d Love to Change the World |
Cash transfer prgms |
| 7/15/10 |
Fio Cruise |
ROW and Fiocruz |
| 7/9/10 |
A Day Late and Many Dollars Short |
NIH trials fund |
| 7/1/10 |
News Flash from Puzzler Tower |
GH sites |
| 6/24/10 |
Una Sorpresa Prometedora |
Archivel TB vaccine |
| 6/17/10 |
The Emperor’s New Clothes |
Com Cap and IOWH |
| 6/10/10 |
AMFm: Not Your Ordinary Radio |
AMFm |
| 6/3/10 |
Access to Medicines/Access to Markets |
CHAI DAT strategy |
| 5/27/10 |
Commercialization: a Going Concern |
SE |
| 5/20/10 |
MedTech Made Easy |
BU Medtech meeting |
| 5/13/10 |
Thinking Out of the Box |
Dx |
| 5/6/10 |
BIO Break |
More reflection |
| 4/29/10 |
Moving Along Smartly |
Smart GH comm. |
| 4/22/10 |
Medical Diplomacy: a Ship of State Adrift |
SE |
| 4/15/10 |
Too Much Alarm (and Not Enough Cow) Bell |
Globe article on HIV |
| 4/8/10 |
DIY Vaccines |
SE |
| 4/1/10 |
USAID and Innovation |
SE |
| 3/25/10 |
A New Deal Against TB |
Crit Path Inst |
| 3/18/10 |
Pictures in an Exhibition |
Reflection on life |
| 3/11/10 |
Accelerated POC |
SE |
| 3/4/10 |
Exertion Toward a Common Object |
Networking |
| 2/25/10 |
Where Does This PATH Lead? |
SE |
| 2/18/10 |
Watering the Grass |
Social venturing |
| 2/11/10 |
PDP Performance Measurement |
SE |
| 2/4/10 |
Official US Government Global Health Program |
SE |
| 1/28/10 |
GSK in the Lead but Who Will Follow |
SE |
| 1/21/10 |
Creating the Upside |
IFFI |
| 1/14/10 |
PRIs for Global Health |
SE |
| 1/7/10 |
Lifting the Burden |
Intl development |
| 12/17/09 |
SEAMs Right |
MSH pharmacies |
| 12/10/09 |
Technology Fix or Fixation? |
PATH vvms |
| 12/3/09 |
Peloton Partnering: A Friend for FRIND |
SE |
| 11/24/09 |
Gates Foundation: For-Profits Need Not Apply? |
SE |
| 11/12/09 |
An Academic Approach to Global Health |
AUTM lic prins |
| 11/5/09 |
The SBIR Drop in the Bucket |
SE |
| 10/28/09 |
A Holy Grail |
Aktiv-Dry vaccine |
| 10/20/09 |
Heads Up, Pharma |
Emerging markets |
| 10/13/09 |
Is there a Bottom Line behind the Headline? |
Hilleman Labs |
| 10/5/09 |
Swimming in the Patent Pool |
GSK patent pool |
| 9/27/09 |
Converting Inspiration to Investment |
BVGH case studies |
| 9/22/09 |
BVGH: at a Critical Junction? |
BVGH |
| 9/15/09 |
Generic Open License Revisited |
Licensing scheme |
